Skip to main content

Table 1 Baseline characteristics of study population by sex

From: Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study

Characteristic

Women

Men

Overall

Standardized difference

p-value

N = 27,535

 N = 24,894

 N = 52,429

Age in years, median (Q1, Q3)

43 (29, 56)

42 (29, 56)

42 (29, 56)

0.03

< 0.001

Major cardiovascular disease (recent myocardial infarction* or lifetime history of heart failure)

552 (2.0%)

633 (2.5%)

1,185 (2.3%)

0.04

< 0.001

Hypertension

6,288 (22.8%)

5,987 (24.0%)

12,275 (23.4%)

0.03

0.001

Diabetes

3,679 (13.4%)

3,657 (14.7%)

7,336 (14.0%)

0.04

< 0.001

Recent cancer*

563 (2.0%)

403 (1.6%)

966 (1.8%)

0.03

< 0.001

Chronic obstructive pulmonary disease (COPD)

1,236 (4.5%)

1,230 (4.9%)

2,466 (4.7%)

0.02

0.015

Stage 4/5 chronic kidney disease (CKD)†

167 (0.6%)

183 (0.7%)

350 (0.7%)

0.02

<0.001

Undetermined CKD status

8,070 (29.3%)

9,635 (38.7%)

17,705 (33.8%)

0.2

Chronic dialysis

55 (0.2%)

91 (0.4%)

146 (0.3%)

0.03

< 0.001

Frailty‡

1,020 (3.7%)

774 (3.1%)

1,794 (3.4%)

0.03

< 0.001

  1. * Hospitalization (for myocardial infarction) or diagnosis (for cancer) within the prior 5 years
  2. † Defined as receiving chronic dialysis or eGFR < 30ml/min/m2* using the most recent serum creatinine result up to 2 years prior to positive SARS-CoV-2 test
  3. ‡ Defined using the Johns Hopkins frailty indicator from The Johns Hopkins ACG ® System Version 10.0